AAPG

MKT CAP:$2B

Ascentage Pharma Group International

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$20.18-$6.19 (-23.47%)

Jul 15, 2026

52W High $47.9052W Low $16.77

Company Details

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a...

Leadership

Dajun Yang M.D., Ph.D.Founder

Co-Founder, Chairman & CEO

Shaomeng Wang Ph.D.Founder

Co-Founder, Chief Scientific Advisor & Non-Executive Director

Ming GuoFounder

Co-Founder

Veet Misra

Chief Financial Officer

Yuly Chen

Senior Director of Investor Relations

Thomas Joseph Knapp J.D.

Senior VP & General Counsel

Yifan Zhai M.D., Ph.D.

Chief Medical Officer

Chongdong Fu

Senior VP & Head of CMC

Jin Cao

Head of Finance

Zhichao Si

Head of Commercial

IPO Date

Jan 24, 2025

Website

www.ascentage.cn

Key Metrics TTM (CNY)

Revenue

¥1.1B

-28.0% YoY

Net Income

-¥2.4B

EPS (Diluted)

Free Cash Flow

-¥1.3B

Revenue / Share

¥11.43

Gross Margin

83.7%

Operating Margin

-226.9%

Net Margin

-230.4%

FCF Margin

-126.5%

P/S

P/E

Revenue & Profitability (CNY)

Operating Cash Flow (CNY)

CapEx Spend (CNY)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CNY)

OpEx Breakdown (CNY)

War Chest (CNY)

Shares Outstanding

Revenue Per Employee (CNY)

Revenue / Employee